Sökning: onr:"swepub:oai:gup.ub.gu.se/271576" > Ochoa syndrome: a s...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03342naa a2200757 4500 | |
001 | oai:gup.ub.gu.se/271576 | |
003 | SwePub | |
008 | 240528s2010 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/2715762 URI |
024 | 7 | a https://doi.org/10.1007/s00431-009-1042-92 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Aydogdu, Özgu,d 1978u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi,Institute of Neuroscience and Physiology, Department of Pharmacology4 aut0 (Swepub:gu)xaydzg |
245 | 1 0 | a Ochoa syndrome: a spectrum of urofacial syndrome. |
264 | c 2009-08-11 | |
264 | 1 | b Springer Science and Business Media LLC,c 2010 |
520 | a The urofacial syndrome, also known as Ochoa syndrome, is a rare autosomal recessive condition that occurs in both genders and characterized by uropathy and facial abnormalities. Early diagnosis is crucial for the management and prognosis of urinary problems due to a dysfunctional bladder. We report 11 patients with urofacial syndrome in five families from Turkey with a median follow up of 32 months (range, 2-44 months). | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Pediatrik0 (SwePub)302212 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Pediatrics0 (SwePub)302212 hsv//eng |
653 | a Abnormalities | |
653 | a Multiple | |
653 | a Antibiotic Prophylaxis | |
653 | a methods | |
653 | a Catheterization | |
653 | a methods | |
653 | a Child | |
653 | a Cholinergic Antagonists | |
653 | a therapeutic use | |
653 | a Combined Modality Therapy | |
653 | a Face | |
653 | a abnormalities | |
653 | a Facial Expression | |
653 | a Follow-Up Studies | |
653 | a Humans | |
653 | a Male | |
653 | a Syndrome | |
653 | a Urinary Bladder | |
653 | a Neurogenic | |
653 | a complications | |
653 | a therapy | |
653 | a Urinary Incontinence | |
653 | a complications | |
653 | a therapy | |
653 | a Urinary Tract Infections | |
653 | a complications | |
653 | a therapy | |
653 | a Vesico-Ureteral Reflux | |
653 | a complications | |
653 | a therapy | |
700 | 1 | a Burgu, Berk4 aut |
700 | 1 | a Demirel, Fuat4 aut |
700 | 1 | a Soygur, Tarkan4 aut |
700 | 1 | a Ozcakar, Zeynep Birsin4 aut |
700 | 1 | a Yalcinkaya, Fatos4 aut |
700 | 1 | a Tekgul, Serdar4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi4 org |
773 | 0 | t European journal of pediatricsd : Springer Science and Business Media LLCg 169:4, s. 431-5q 169:4<431-5x 1432-1076x 0340-6199 |
856 | 4 8 | u https://gup.ub.gu.se/publication/271576 |
856 | 4 8 | u https://doi.org/10.1007/s00431-009-1042-9 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.